Plasma biomarkers of Alzheimer’s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations

QR Code

Plasma biomarkers of Alzheimer’s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations

Plasma biomarkers of amyloid, tau and neurodegeneration (ATN) need to be characterized in cognitively unimpaired (CU) elderly individuals. Here, the authors show plasma ATN biomarkers predict clinical deterioration and cognitive decline and show in a simulated clinical trial combining all three biom...

Full description

Saved in:

Bibliographic Details
Main Authors:	Nicholas C. Cullen, Antoine Leuzy, Shorena Janelidze, Sebastian Palmqvist, Anna L. Svenningsson, Erik Stomrud, Jeffrey L. Dage, Niklas Mattsson-Carlgren, Oskar Hansson
Format:	article
Language:	EN
Published:	Nature Portfolio 2021
Subjects:	Science Q
Online Access:	https://doaj.org/article/ed33539191794e8abd8ebdc03d75b61a
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Genetic effects on longitudinal cognitive decline during the early stages of Alzheimer’s disease
by: Atul Kumar, et al.
Published: (2021)

Accelerated inflammatory aging in Alzheimer’s disease and its relation to amyloid, tau, and cognition
by: Nicholas C. Cullen, et al.
Published: (2021)

Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
by: Niklas Mattsson-Carlgren, et al.
Published: (2021)

Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
by: Niklas Mattsson-Carlgren, et al.
Published: (2020)

Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
by: Shorena Janelidze, et al.
Published: (2020)

Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study.
by: Sebastian Palmqvist, et al.
Published: (2012)

Cognitive declines precede and predict functional declines in aging and Alzheimer's disease.
by: Laura B Zahodne, et al.
Published: (2013)

Sex Differences in Cognitive Decline in Subjects with High Likelihood of Mild Cognitive Impairment due to Alzheimer’s disease
by: Dongwha Sohn, et al.
Published: (2018)

Aspirin using was associated with slower cognitive decline in patients with Alzheimer's disease.
by: Jinyan Weng, et al.
Published: (2021)

Epigenetic Mechanisms in Memory and Cognitive Decline Associated with Aging and Alzheimer’s Disease
by: Sabyasachi Maity, et al.
Published: (2021)

Screening for subjective cognitive decline in the elderly via subjective cognitive complaints and informant-reported questionnaires: a systematic review
by: Sara Wasef, et al.
Published: (2021)

Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis
by: Niklas Mattsson, et al.
Published: (2016)

A novel olfactory threshold test for screening cognitive decline among elderly people.
by: Sun Mi Kim, et al.
Published: (2021)

Conversion From The Korean Dementia Screening Questionnaire To The Informant Questionnaire On Cognitive Decline In The Elderly
by: Yeo TY, et al.
Published: (2019)

Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
by: Sebastian Palmqvist, et al.
Published: (2017)

Plasma MCP-1 and Cognitive Decline in Patients with Alzheimer’s Disease and Mild Cognitive Impairment: A Two-year Follow-up Study
by: Wei-Ju Lee, et al.
Published: (2018)

Effects of Transcutaneous Electrical Acupoint Stimulation on Postoperative Cognitive Decline in Elderly Patients: A Pilot Study
by: Liu T, et al.
Published: (2021)

PREVALENCE OF COGNITIVE DECLINE IN PATIENTS WITH STROKE
by: Fatima Naseem Malik, et al.
Published: (2020)

Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease
by: Edmond Teng, et al.
Published: (2021)

Body, Brain, Life for Cognitive Decline (BBL-CD): protocol for a multidomain dementia risk reduction randomized controlled trial for subjective cognitive decline and mild cognitive impairment
by: McMaster M, et al.
Published: (2018)

Impact of Catheter Ablation on Stroke, Cognitive Decline and Dementia
by: Tyson S Burnham, et al.
Published: (2021)

From mild cognitive impairment to subjective cognitive decline: conceptual and methodological evolution
by: Cheng YW, et al.
Published: (2017)

Anaemia and cerebrospinal fluid biomarkers of Alzheimer’s pathology in cognitively normal elders: the CABLE study
by: Xin-Yu Yang, et al.
Published: (2021)

The Correlation Between Hearing Loss, Especially High-Frequency Hearing Loss and Cognitive Decline Among the Elderly
by: Tongxiang Diao, et al.
Published: (2021)

Dietary acrylamide exposure was associated with mild cognition decline among non-smoking Chinese elderly men
by: Zhao-min Liu, et al.
Published: (2017)

Alpha-Synuclein and Cognitive Decline in Parkinson Disease
by: Tian-Sin Fan, et al.
Published: (2021)

A microRNA signature that correlates with cognition and is a target against cognitive decline
by: Md Rezaul Islam, et al.
Published: (2021)

Paracetamol (acetaminophen) rescues cognitive decline, neuroinflammation and cytoskeletal alterations in a model of post-operative cognitive decline (POCD) in middle-aged rats
by: B. Garrone, et al.
Published: (2021)

Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging
by: Joseph Flores, et al.
Published: (2020)

Faster cognitive and functional decline in Dysexecutive versus amnestic Alzheimer's subgroups: a longitudinal analysis of the National Alzheimer's Coordinating Center (NACC) database.
by: Jesse Mez, et al.
Published: (2013)

Plasma Total Tau and Neurobehavioral Symptoms of Cognitive Decline in Cognitively Normal Older Adults
by: James R. Hall, et al.
Published: (2021)

Plasma N-terminal tau fragment levels predict future cognitive decline and neurodegeneration in healthy elderly individuals
by: Jasmeer P. Chhatwal, et al.
Published: (2020)

Kidney function and cognitive decline in an oldest-old Chinese population
by: Bai K, et al.
Published: (2017)

Moderate decline in select synaptic markers in the prefrontal cortex (BA9) of patients with Alzheimer’s disease at various cognitive stages
by: Odile Poirel, et al.
Published: (2018)

Spatial variation of perfusion MRI reflects cognitive decline in mild cognitive impairment and early dementia
by: Catherine A. Morgan, et al.
Published: (2021)

Evaluation of Available Cognitive Tools Used to Measure Mild Cognitive Decline: A Scoping Review
by: Chian Thong Chun, et al.
Published: (2021)

Risk factors for subjective cognitive decline: the CABLE study
by: Chen Wen, et al.
Published: (2021)

Publisher Correction: Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging
by: Joseph Flores, et al.
Published: (2021)

Beneficial effects of multisensory and cognitive stimulation on age-related cognitive decline in long-term-care institutions
by: Oliveira TCG, et al.
Published: (2014)

The size-weight illusion is unimpaired in individuals with a history of congenital visual deprivation
by: Rashi Pant, et al.
Published: (2021)